Loading clinical trials...
Loading clinical trials...
This study is designed as a single-center, phase II exploratory clinical trial to evaluate the pathological response rate and safety of sintilimab (PD-1 inhibitor) combined with XELOX regimen (oxalipl...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The First Affiliated Hospital of Anhui Medical University
NCT07066046 · Colorectal Cancer (CRC), Adenomatous Polyposis, and more
NCT07432633 · Colorectal Cancer, Epithelial Ovarian Cancer, and more
NCT07162337 · Colorectal Cancer Prevention, Colorectal Adenoma
NCT06287723 · Colorectal Cancer, Liver Metastases, and more
NCT05780684 · Colorectal Cancer, Esophagus Cancer, and more
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions